A citation-based method for searching scientific literature

Stephen J Schuster, Michael R Bishop, Constantine S Tam, Edmund K Waller, Peter Borchmann, Joseph P McGuirk, Ulrich Jäger, Samantha Jaglowski, Charalambos Andreadis, Jason R Westin, Isabelle Fleury, Veronika Bachanova, S Ronan Foley, P Joy Ho, Stephan Mielke, John M Magenau, Harald Holte, Serafino Pantano, Lida B Pacaud, Rakesh Awasthi, Jufen Chu, Özlem Anak, Gilles Salles, Richard T Maziarz. N Engl J Med 2019
Times Cited: 1342







List of co-cited articles
694 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Outcomes of older patients in ZUMA-1, a pivotal study of axicabtagene ciloleucel in refractory large B-cell lymphoma.
Sattva S Neelapu, Caron A Jacobson, Olalekan O Oluwole, Javier Munoz, Abhinav Deol, David B Miklos, Nancy L Bartlett, Ira Braunschweig, Yizhou Jiang, Jenny J Kim,[...]. Blood 2020
38
10

Safety and feasibility of anti-CD19 CAR T cells with fully human binding domains in patients with B-cell lymphoma.
Jennifer N Brudno, Norris Lam, Danielle Vanasse, Yueh-Wei Shen, Jeremy J Rose, John Rossi, Allen Xue, Adrian Bot, Nathalie Scholler, Lekha Mikkilineni,[...]. Nat Med 2020
93
4

CD40 Ligand-Modified Chimeric Antigen Receptor T Cells Enhance Antitumor Function by Eliciting an Endogenous Antitumor Response.
Nicholas F Kuhn, Terence J Purdon, Dayenne G van Leeuwen, Andrea V Lopez, Kevin J Curran, Anthony F Daniyan, Renier J Brentjens. Cancer Cell 2019
91
4

Human T-lymphocyte cytotoxicity and proliferation directed by a single chimeric TCRzeta /CD28 receptor.
John Maher, Renier J Brentjens, Gertrude Gunset, Isabelle Rivière, Michel Sadelain. Nat Biotechnol 2002
615
4

Cytokine release syndrome.
Alexander Shimabukuro-Vornhagen, Philipp Gödel, Marion Subklewe, Hans Joachim Stemmler, Hans Anton Schlößer, Max Schlaak, Matthias Kochanek, Boris Böll, Michael S von Bergwelt-Baildon. J Immunother Cancer 2018
600
4

The response to lymphodepletion impacts PFS in patients with aggressive non-Hodgkin lymphoma treated with CD19 CAR T cells.
Alexandre V Hirayama, Jordan Gauthier, Kevin A Hay, Jenna M Voutsinas, Qian Wu, Ted Gooley, Daniel Li, Sindhu Cherian, Xueyan Chen, Barbara S Pender,[...]. Blood 2019
129
4

Single-Cell Analyses Identify Brain Mural Cells Expressing CD19 as Potential Off-Tumor Targets for CAR-T Immunotherapies.
Kevin R Parker, Denis Migliorini, Eric Perkey, Kathryn E Yost, Aparna Bhaduri, Puneet Bagga, Mohammad Haris, Neil E Wilson, Fang Liu, Khatuna Gabunia,[...]. Cell 2020
116
4

CAR T cell-induced cytokine release syndrome is mediated by macrophages and abated by IL-1 blockade.
Theodoros Giavridis, Sjoukje J C van der Stegen, Justin Eyquem, Mohamad Hamieh, Alessandra Piersigilli, Michel Sadelain. Nat Med 2018
518
4

CAR-T efficacy: is conditioning the key?
Sattva S Neelapu. Blood 2019
42
9

Monocyte-derived IL-1 and IL-6 are differentially required for cytokine-release syndrome and neurotoxicity due to CAR T cells.
Margherita Norelli, Barbara Camisa, Giulia Barbiera, Laura Falcone, Ayurzana Purevdorj, Marco Genua, Francesca Sanvito, Maurilio Ponzoni, Claudio Doglioni, Patrizia Cristofori,[...]. Nat Med 2018
604
4


Genetic mechanisms of target antigen loss in CAR19 therapy of acute lymphoblastic leukemia.
Elena J Orlando, Xia Han, Catherine Tribouley, Patricia A Wood, Rebecca J Leary, Markus Riester, John E Levine, Muna Qayed, Stephan A Grupp, Michael Boyer,[...]. Nat Med 2018
228
4

High rate of durable complete remission in follicular lymphoma after CD19 CAR-T cell immunotherapy.
Alexandre V Hirayama, Jordan Gauthier, Kevin A Hay, Jenna M Voutsinas, Qian Wu, Barbara S Pender, Reed M Hawkins, Aesha Vakil, Rachel N Steinmetz, Stanley R Riddell,[...]. Blood 2019
84
4

Optimized tandem CD19/CD20 CAR-engineered T cells in refractory/relapsed B-cell lymphoma.
Chuan Tong, Yajing Zhang, Yang Liu, Xingyu Ji, Wenying Zhang, Yelei Guo, Xiao Han, Dongdong Ti, Hanren Dai, Chunmeng Wang,[...]. Blood 2020
61
6

The model of cytokine release syndrome in CAR T-cell treatment for B-cell non-Hodgkin lymphoma.
Jianshu Wei, Yang Liu, Chunmeng Wang, Yajing Zhang, Chuan Tong, Guanghai Dai, Wei Wang, John E J Rasko, J Joseph Melenhorst, Wenbin Qian,[...]. Signal Transduct Target Ther 2020
42
9

CD27 costimulation augments the survival and antitumor activity of redirected human T cells in vivo.
De-Gang Song, Qunrui Ye, Mathilde Poussin, Gretchen M Harms, Mariangela Figini, Daniel J Powell. Blood 2012
218
4

A phase I study on adoptive immunotherapy using gene-modified T cells for ovarian cancer.
Michael H Kershaw, Jennifer A Westwood, Linda L Parker, Gang Wang, Zelig Eshhar, Sharon A Mavroukakis, Donald E White, John R Wunderlich, Silvana Canevari, Linda Rogers-Freezer,[...]. Clin Cancer Res 2006
802
4

Managing cytokine release syndrome associated with novel T cell-engaging therapies.
Shannon L Maude, David Barrett, David T Teachey, Stephan A Grupp. Cancer J 2014
459
4

Engineering strategies to overcome the current roadblocks in CAR T cell therapy.
Sarwish Rafiq, Christopher S Hackett, Renier J Brentjens. Nat Rev Clin Oncol 2020
323
4

Comparing Efficacy, Safety, and Preinfusion Period of Axicabtagene Ciloleucel versus Tisagenlecleucel in Relapsed/Refractory Large B Cell Lymphoma.
Olalekan O Oluwole, Jeroen P Jansen, Vincent W Lin, Keith Chan, Sam Keeping, Lynn Navale, Frederick L Locke. Biol Blood Marrow Transplant 2020
17
23

Emerging Cellular Therapies for Cancer.
Sonia Guedan, Marco Ruella, Carl H June. Annu Rev Immunol 2019
166
4

'Off-the-shelf' allogeneic CAR T cells: development and challenges.
S Depil, P Duchateau, S A Grupp, G Mufti, L Poirot. Nat Rev Drug Discov 2020
248
4

CRISPR-Cas9 disruption of PD-1 enhances activity of universal EGFRvIII CAR T cells in a preclinical model of human glioblastoma.
Bryan D Choi, Xiaoling Yu, Ana P Castano, Henia Darr, Daniel B Henderson, Amanda A Bouffard, Rebecca C Larson, Irene Scarfò, Stefanie R Bailey, Genevieve M Gerhard,[...]. J Immunother Cancer 2019
93
4

Targeted delivery of a PD-1-blocking scFv by CAR-T cells enhances anti-tumor efficacy in vivo.
Sarwish Rafiq, Oladapo O Yeku, Hollie J Jackson, Terence J Purdon, Dayenne G van Leeuwen, Dylan J Drakes, Mei Song, Matthew M Miele, Zhuoning Li, Pei Wang,[...]. Nat Biotechnol 2018
331
4

A Chimeric Switch-Receptor Targeting PD1 Augments the Efficacy of Second-Generation CAR T Cells in Advanced Solid Tumors.
Xiaojun Liu, Raghuveer Ranganathan, Shuguang Jiang, Chongyun Fang, Jing Sun, Soyeon Kim, Kheng Newick, Albert Lo, Carl H June, Yangbing Zhao,[...]. Cancer Res 2016
294
4

A guide to cancer immunotherapy: from T cell basic science to clinical practice.
Alex D Waldman, Jill M Fritz, Michael J Lenardo. Nat Rev Immunol 2020
672
4

Next generation chimeric antigen receptor T cells: safety strategies to overcome toxicity.
Shengnan Yu, Ming Yi, Shuang Qin, Kongming Wu. Mol Cancer 2019
111
4

Blinatumomab versus Chemotherapy for Advanced Acute Lymphoblastic Leukemia.
Hagop Kantarjian, Anthony Stein, Nicola Gökbuget, Adele K Fielding, Andre C Schuh, Josep-Maria Ribera, Andrew Wei, Hervé Dombret, Robin Foà, Renato Bassan,[...]. N Engl J Med 2017
894
4

Infusion of donor-derived CD19-redirected virus-specific T cells for B-cell malignancies relapsed after allogeneic stem cell transplant: a phase 1 study.
Conrad Russell Y Cruz, Kenneth P Micklethwaite, Barbara Savoldo, Carlos A Ramos, Sharon Lam, Stephanie Ku, Oumar Diouf, Enli Liu, A John Barrett, Sawa Ito,[...]. Blood 2013
369
4

Safety and activity of the anti-CD79B antibody-drug conjugate polatuzumab vedotin in relapsed or refractory B-cell non-Hodgkin lymphoma and chronic lymphocytic leukaemia: a phase 1 study.
Maria Corinna A Palanca-Wessels, Myron Czuczman, Gilles Salles, Sarit Assouline, Laurie H Sehn, Ian Flinn, Manish R Patel, Randeep Sangha, Anton Hagenbeek, Ranjana Advani,[...]. Lancet Oncol 2015
171
4


CAR-T cell therapy: current limitations and potential strategies.
Robert C Sterner, Rosalie M Sterner. Blood Cancer J 2021
86
4

Integration of a CD19 CAR into the TCR Alpha Chain Locus Streamlines Production of Allogeneic Gene-Edited CAR T Cells.
Daniel T MacLeod, Jeyaraj Antony, Aaron J Martin, Rachel J Moser, Armin Hekele, Keith J Wetzel, Audrey E Brown, Melissa A Triggiano, Jo Ann Hux, Christina D Pham,[...]. Mol Ther 2017
120
4

Engineering CAR-T Cells for Next-Generation Cancer Therapy.
Mihe Hong, Justin D Clubb, Yvonne Y Chen. Cancer Cell 2020
109
4

A foundation for universal T-cell based immunotherapy: T cells engineered to express a CD19-specific chimeric-antigen-receptor and eliminate expression of endogenous TCR.
Hiroki Torikai, Andreas Reik, Pei-Qi Liu, Yuanyue Zhou, Ling Zhang, Sourindra Maiti, Helen Huls, Jeffrey C Miller, Partow Kebriaei, Brian Rabinovich,[...]. Blood 2012
313
4

Outcomes of patients with large B-cell lymphoma progressing after axicabtagene ciloleucel therapy.
Jay Y Spiegel, Saurabh Dahiya, Michael D Jain, John Tamaresis, Loretta J Nastoupil, Miriam T Jacobs, Armin Ghobadi, Yi Lin, Matthew Lunning, Lazaros Lekakis,[...]. Blood 2021
22
18

Genetics and Pathogenesis of Diffuse Large B-Cell Lymphoma.
Roland Schmitz, George W Wright, Da Wei Huang, Calvin A Johnson, James D Phelan, James Q Wang, Sandrine Roulland, Monica Kasbekar, Ryan M Young, Arthur L Shaffer,[...]. N Engl J Med 2018
749
4

Induction of resistance to chimeric antigen receptor T cell therapy by transduction of a single leukemic B cell.
Marco Ruella, Jun Xu, David M Barrett, Joseph A Fraietta, Tyler J Reich, David E Ambrose, Michael Klichinsky, Olga Shestova, Prachi R Patel, Irina Kulikovskaya,[...]. Nat Med 2018
260
4

Multiplex Genome Editing to Generate Universal CAR T Cells Resistant to PD1 Inhibition.
Jiangtao Ren, Xiaojun Liu, Chongyun Fang, Shuguang Jiang, Carl H June, Yangbing Zhao. Clin Cancer Res 2017
466
4

HLA-E-expressing pluripotent stem cells escape allogeneic responses and lysis by NK cells.
Germán G Gornalusse, Roli K Hirata, Sarah E Funk, Laura Riolobos, Vanda S Lopes, Gabriel Manske, Donna Prunkard, Aric G Colunga, Laïla-Aïcha Hanafi, Dennis O Clegg,[...]. Nat Biotechnol 2017
232
4

Reprogramming human T cell function and specificity with non-viral genome targeting.
Theodore L Roth, Cristina Puig-Saus, Ruby Yu, Eric Shifrut, Julia Carnevale, P Jonathan Li, Joseph Hiatt, Justin Saco, Paige Krystofinski, Han Li,[...]. Nature 2018
324
4

An "off-the-shelf" fratricide-resistant CAR-T for the treatment of T cell hematologic malignancies.
Matthew L Cooper, Jaebok Choi, Karl Staser, Julie K Ritchey, Jessica M Devenport, Kayla Eckardt, Michael P Rettig, Bing Wang, Linda G Eissenberg, Armin Ghobadi,[...]. Leukemia 2018
162
4

Development of CAR T-cell lymphoma in 2 of 10 patients effectively treated with piggyBac-modified CD19 CAR T cells.
David C Bishop, Leighton E Clancy, Renee Simms, Jane Burgess, Geetha Mathew, Leili Moezzi, Janine A Street, Gaurav Sutrave, Elissa Atkins, Helen M McGuire,[...]. Blood 2021
25
16

Toward eliminating HLA class I expression to generate universal cells from allogeneic donors.
Hiroki Torikai, Andreas Reik, Frank Soldner, Edus H Warren, Carrie Yuen, Yuanyue Zhou, Denise L Crossland, Helen Huls, Nicholas Littman, Ziying Zhang,[...]. Blood 2013
183
4

PD-1 blockade with nivolumab in relapsed or refractory Hodgkin's lymphoma.
Stephen M Ansell, Alexander M Lesokhin, Ivan Borrello, Ahmad Halwani, Emma C Scott, Martin Gutierrez, Stephen J Schuster, Michael M Millenson, Deepika Cattry, Gordon J Freeman,[...]. N Engl J Med 2015
4

Low-Dose Radiation Conditioning Enables CAR T Cells to Mitigate Antigen Escape.
Carl DeSelm, M Lia Palomba, Joachim Yahalom, Mohamad Hamieh, Justin Eyquem, Vinagolu K Rajasekhar, Michel Sadelain. Mol Ther 2018
86
4

Side-effect management of chimeric antigen receptor (CAR) T-cell therapy.
M-L Schubert, M Schmitt, L Wang, C A Ramos, K Jordan, C Müller-Tidow, P Dreger. Ann Oncol 2021
48
8

Ibrutinib versus temsirolimus in patients with relapsed or refractory mantle-cell lymphoma: an international, randomised, open-label, phase 3 study.
Martin Dreyling, Wojciech Jurczak, Mats Jerkeman, Rodrigo Santucci Silva, Chiara Rusconi, Marek Trneny, Fritz Offner, Dolores Caballero, Cristina Joao, Mathias Witzens-Harig,[...]. Lancet 2016
286
4

Preclinical Development of Bivalent Chimeric Antigen Receptors Targeting Both CD19 and CD22.
Haiying Qin, Sneha Ramakrishna, Sang Nguyen, Thomas J Fountaine, Anusha Ponduri, Maryalice Stetler-Stevenson, Constance M Yuan, Waleed Haso, Jack F Shern, Nirali N Shah,[...]. Mol Ther Oncolytics 2018
118
4

Clinical lessons learned from the first leg of the CAR T cell journey.
Robbie G Majzner, Crystal L Mackall. Nat Med 2019
194
4


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.